Company Profile
Updated: 23-MAR-06Axcan Pharma Inc.
International public company
597 boul. Laurier, Mont Saint-Hilaire, CANPQ J3H 6C4, Canada
(450)4675138, (450)4649979 fax, http://www.axcan.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Biotechnology & pharmaceutical
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Ex-Ropes & Gray lawyer pleads guilty in Galleon scheme
The Boston Globe; 12/11/2009; 509 words; ...tips involved two transactions, Bain Capital Partners' acquisition of 3Com Corp. and TPG Capital's purchase of Axcan Pharma Inc. Ropes & Gray represented Bain and TPG in the 2007 deals, according to court papers. "The actions of these two...
SEC CHARGES ADDITIONAL ATTORNEY IN $20 MILLION INSIDER TRADING SCHEME
US Fed News Service, Including US State News; 12/11/2009; 605 words; ...information concerning at least two corporate acquisitions involving Ropes & Gray clients -3Com Corp. and Axcan Pharma Inc. The complaint alleges that Santarlas gained access to material, nonpublic information by, among other means...
Ex-lawyer admits guilt in insider trading case
AP Worldstream; 12/10/2009; 802 words; ...bid for 3Com Corp. and TPG Capital's acquisition of Axcan Pharma Inc. _ led to $20 million in illegal profits. According...3Com deal and $25,000 in cash for secrets about the Axcan acquisition. As part of his plea, Santarlas agreed...
Sixth Person admits Fraud in Galleon Insider Case
Reuters Hedgeworld; 12/10/2009; 669 words; ...confidential information about acquisitions of 3Com Inc. technology company and Axcan Pharma Inc. "I knew what I was doing was wrong," Mr...announced on Nov. 29, 2007 that it was acquiring Axcan Pharma. U.S. prosecutors said Mr. Santarlas...
Cellerix Gets [euro]27M in First Closing for Stem Cell Therapy.
BioWorld International; 11/18/2009; 1065 words; ...hit-and-run strategy," he said. Montreal-based Axcan Pharma Inc. licensed U.S. rights to Ontaril two years ago...Bravo said. "It's a very small target audience." Axcan also retains an option on Cx601, which physicians will...
Recent News Articles
- Axcan Pharma Inc. - Strategic Analysis Review.
M2 Presswire - May 12, 2009 - Axcan Pharma Inc. - a Comprehensive Insight into the Company, Including Business Structure and Operations, Executive Biographies and Key Competitors.(Company overview)
Biotech Week - May 06, 2009 - Research and Markets: Axcan Pharma Inc. - a Comprehensive Insight into the Company, Including Business Structure and Operations, Executive Biographies and Key Competitors.(Company overview)
Business Wire - April 16, 2009 - Axcan Pharma Inc. - A Comprehensive Insight Into The Company, Including Business Structure And Operations, Executive Biographies And Key Competitors.
M2 Presswire - April 16, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning